APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microneedle Flu Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Microneedle Flu Vaccine Industry Growth and Trends Forecast to 2032

29 December 202593 pages

Choose your research edition.

Industry ResearchMicroneedle Flu Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Microneedle Flu Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Microneedle Flu Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microneedle Flu Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Microneedle Flu Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Microneedle Flu Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microneedle Flu Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Microneedle Flu Vaccine include Sanofi, NanoPass Technologies, Microdermics and OraSure Technologies, GC Pharma, FluGen, Debiotech, CosMED Pharmaceuticals, Corium International and Becton Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Microneedle Flu Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Microneedle Flu Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Microneedle Flu Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Microneedle Flu Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Microneedle Flu Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Microneedle Flu Vaccine Market by Company

Sanofi

NanoPass Technologies

Microdermics and OraSure Technologies

GC Pharma

FluGen

Debiotech

CosMED Pharmaceuticals

Corium International

Becton Dickinson and Company

Microneedle Flu Vaccine Segment by Type

Hollow Microneedle

Coated Microneedle

Solid Microneedle

Dissolving Microneedle

Microneedle Flu Vaccine Segment by Application

Influenza A

Influenza B

Microneedle Flu Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microneedle Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Flu Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Microneedle Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hollow Microneedle Table 2. Major Company of Coated Microneedle Table 3. Major Company of Solid Microneedle Table 4. Major Company of Dissolving Microneedle Table 5. Global Microneedle Flu Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 7. Global Microneedle Flu Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Microneedle Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Microneedle Flu Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Microneedle Flu Vaccine Price by Type (2021-2026) & (US$/Unit) Table 11. Global Microneedle Flu Vaccine Sales by Type (2027-2032) & (K Units) Table 12. Global Microneedle Flu Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Microneedle Flu Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Microneedle Flu Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Microneedle Flu Vaccine Price by Type (2027-2032) & (US$/Unit) Table 16. North America Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 17. North America Microneedle Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Europe Microneedle Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Microneedle Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Latin America Microneedle Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Microneedle Flu Vaccine Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Microneedle Flu Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Microneedle Flu Vaccine Industry Trends Table 27. Microneedle Flu Vaccine Industry Drivers Table 28. Microneedle Flu Vaccine Industry Opportunities and Challenges Table 29. Microneedle Flu Vaccine Industry Restraints Table 30. Global Microneedle Flu Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Microneedle Flu Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Microneedle Flu Vaccine Sales by Company (2021-2026) & (K Units) Table 33. Global Microneedle Flu Vaccine Sales Share by Company (2021-2026) Table 34. Global Microneedle Flu Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Microneedle Flu Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Microneedle Flu Vaccine Major Company Production Sites and Headquarters Table 37. Global Microneedle Flu Vaccine Company, Product Type & Application Table 38. Global Microneedle Flu Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Microneedle Flu Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Microneedle Flu Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Microneedle Flu Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Microneedle Flu Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Microneedle Flu Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Microneedle Flu Vaccine Sales by Region (2027-2032) & (K Units) Table 48. Global Microneedle Flu Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Microneedle Flu Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Microneedle Flu Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Microneedle Flu Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Microneedle Flu Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 54. Global Microneedle Flu Vaccine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Microneedle Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Microneedle Flu Vaccine Sales Market Share in Value by Application (2021-2026) Table 57. Global Microneedle Flu Vaccine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Microneedle Flu Vaccine Sales by Application (2027-2032) & (K Units) Table 59. Global Microneedle Flu Vaccine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Microneedle Flu Vaccine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Microneedle Flu Vaccine Sales Market Share in Value by Application (2027-2032) Table 62. Global Microneedle Flu Vaccine Price by Application (2027-2032) & (US$/Unit) Table 63. North America Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 64. North America Microneedle Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Europe Microneedle Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Microneedle Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Latin America Microneedle Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Microneedle Flu Vaccine Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Microneedle Flu Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sanofi Microneedle Flu Vaccine Product Portfolio Table 77. Sanofi Recent Development Table 78. NanoPass Technologies Company Information Table 79. NanoPass Technologies Business Overview Table 80. NanoPass Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. NanoPass Technologies Microneedle Flu Vaccine Product Portfolio Table 82. NanoPass Technologies Recent Development Table 83. Microdermics and OraSure Technologies Company Information Table 84. Microdermics and OraSure Technologies Business Overview Table 85. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio Table 87. Microdermics and OraSure Technologies Recent Development Table 88. GC Pharma Company Information Table 89. GC Pharma Business Overview Table 90. GC Pharma Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GC Pharma Microneedle Flu Vaccine Product Portfolio Table 92. GC Pharma Recent Development Table 93. FluGen Company Information Table 94. FluGen Business Overview Table 95. FluGen Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. FluGen Microneedle Flu Vaccine Product Portfolio Table 97. FluGen Recent Development Table 98. Debiotech Company Information Table 99. Debiotech Business Overview Table 100. Debiotech Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Debiotech Microneedle Flu Vaccine Product Portfolio Table 102. Debiotech Recent Development Table 103. CosMED Pharmaceuticals Company Information Table 104. CosMED Pharmaceuticals Business Overview Table 105. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio Table 107. CosMED Pharmaceuticals Recent Development Table 108. Corium International Company Information Table 109. Corium International Business Overview Table 110. Corium International Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Corium International Microneedle Flu Vaccine Product Portfolio Table 112. Corium International Recent Development Table 113. Becton Dickinson and Company Company Information Table 114. Becton Dickinson and Company Business Overview Table 115. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio Table 117. Becton Dickinson and Company Recent Development Table 118. North America Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 120. North America Microneedle Flu Vaccine Sales Market Share by Country (2021-2026) Table 121. North America Microneedle Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Microneedle Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 123. North America Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Microneedle Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Microneedle Flu Vaccine Market Share by Country (2021-2026) Table 126. North America Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Microneedle Flu Vaccine Market Share Forecast by Country (2027-2032) Table 128. Europe Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 130. Europe Microneedle Flu Vaccine Sales Market Share by Country (2021-2026) Table 131. Europe Microneedle Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Microneedle Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Microneedle Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Microneedle Flu Vaccine Market Share by Country (2021-2026) Table 136. Europe Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Microneedle Flu Vaccine Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Microneedle Flu Vaccine Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Microneedle Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Microneedle Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Microneedle Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Microneedle Flu Vaccine Market Share by Country (2021-2026) Table 146. Asia-Pacific Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Microneedle Flu Vaccine Market Share Forecast by Country (2027-2032) Table 148. Latin America Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 150. Latin America Microneedle Flu Vaccine Sales Market Share by Country (2021-2026) Table 151. Latin America Microneedle Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Microneedle Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Microneedle Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Microneedle Flu Vaccine Market Share by Country (2021-2026) Table 156. Latin America Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Microneedle Flu Vaccine Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Microneedle Flu Vaccine Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Microneedle Flu Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Microneedle Flu Vaccine Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Microneedle Flu Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Microneedle Flu Vaccine Market Share by Country (2021-2026) Table 166. Middle East and Africa Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Microneedle Flu Vaccine Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Microneedle Flu Vaccine Distributors List Table 171. Microneedle Flu Vaccine Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Microneedle Flu Vaccine Image Figure 2. Global Microneedle Flu Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microneedle Flu Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Microneedle Flu Vaccine Sales (2021-2032) & (K Units) Figure 5. Hollow Microneedle Image Figure 6. Global Hollow Microneedle Sales YoY Growth (2021-2032) & (K Units) Figure 7. Coated Microneedle Image Figure 8. Global Coated Microneedle Sales YoY Growth (2021-2032) & (K Units) Figure 9. Solid Microneedle Image Figure 10. Global Solid Microneedle Sales YoY Growth (2021-2032) & (K Units) Figure 11. Dissolving Microneedle Image Figure 12. Global Dissolving Microneedle Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Microneedle Flu Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Microneedle Flu Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Microneedle Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Microneedle Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Microneedle Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Microneedle Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Microneedle Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Microneedle Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Microneedle Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Microneedle Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Microneedle Flu Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Microneedle Flu Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Microneedle Flu Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Influenza A Image Figure 28. Global Influenza A Sales YoY Growth (2021-2032) & (K Units) Figure 29. Influenza B Image Figure 30. Global Influenza B Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Microneedle Flu Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Microneedle Flu Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Microneedle Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Microneedle Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Microneedle Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Microneedle Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Microneedle Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Microneedle Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Microneedle Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Microneedle Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Microneedle Flu Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Microneedle Flu Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Microneedle Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Microneedle Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Microneedle Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Microneedle Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Microneedle Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Microneedle Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Microneedle Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Microneedle Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Microneedle Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Microneedle Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Microneedle Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Microneedle Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Microneedle Flu Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Microneedle Flu Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Microneedle Flu Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Microneedle Flu Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Microneedle Flu Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Microneedle Flu Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Hollow Microneedle
  • Coated Microneedle
  • Solid Microneedle
  • Dissolving Microneedle
Applications
  • Influenza A
  • Influenza B
Companies covered
  • Sanofi
  • NanoPass Technologies
  • Microdermics and OraSure Technologies
  • GC Pharma
  • FluGen
  • Debiotech
  • CosMED Pharmaceuticals
  • Corium International
  • Becton Dickinson and Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Microneedle Flu Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Microneedle Flu Vaccine Market by Type
  6. 1.3.1 Hollow Microneedle
  7. 1.3.2 Coated Microneedle
  8. 1.3.3 Solid Microneedle
  9. 1.3.4 Dissolving Microneedle
  10. 1.4 Global Microneedle Flu Vaccine Market Size by Type
  11. 1.4.1 Global Microneedle Flu Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Microneedle Flu Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Microneedle Flu Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Microneedle Flu Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Microneedle Flu Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Microneedle Flu Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Microneedle Flu Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Microneedle Flu Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Microneedle Flu Vaccine Industry Trends
  2. 2.2 Microneedle Flu Vaccine Industry Drivers
  3. 2.3 Microneedle Flu Vaccine Industry Opportunities and Challenges
  4. 2.4 Microneedle Flu Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Microneedle Flu Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Microneedle Flu Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Microneedle Flu Vaccine Price (2021-2026)
  4. 3.4 Global Microneedle Flu Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Microneedle Flu Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Microneedle Flu Vaccine Company, Product Type & Application
  7. 3.7 Global Microneedle Flu Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Microneedle Flu Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Microneedle Flu Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Microneedle Flu Vaccine Tier 1, Tier 2, and Tier 3
4 Microneedle Flu Vaccine Regional Status and Outlook
  1. 4.1 Global Microneedle Flu Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Microneedle Flu Vaccine Historic Market Size by Region
  3. 4.2.1 Global Microneedle Flu Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Microneedle Flu Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Microneedle Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Microneedle Flu Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Microneedle Flu Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Microneedle Flu Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Microneedle Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Microneedle Flu Vaccine by Application
  1. 5.1 Microneedle Flu Vaccine Market by Application
  2. 5.1.1 Influenza A
  3. 5.1.2 Influenza B
  4. 5.2 Global Microneedle Flu Vaccine Market Size by Application
  5. 5.2.1 Global Microneedle Flu Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Microneedle Flu Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Microneedle Flu Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Microneedle Flu Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Microneedle Flu Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Microneedle Flu Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Microneedle Flu Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Microneedle Flu Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 NanoPass Technologies
  8. 6.2.1 NanoPass Technologies Company Information
  9. 6.2.2 NanoPass Technologies Business Overview
  10. 6.2.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
  12. 6.2.5 NanoPass Technologies Recent Developments
  13. 6.3 Microdermics and OraSure Technologies
  14. 6.3.1 Microdermics and OraSure Technologies Company Information
  15. 6.3.2 Microdermics and OraSure Technologies Business Overview
  16. 6.3.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
  18. 6.3.5 Microdermics and OraSure Technologies Recent Developments
  19. 6.4 GC Pharma
  20. 6.4.1 GC Pharma Company Information
  21. 6.4.2 GC Pharma Business Overview
  22. 6.4.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
  24. 6.4.5 GC Pharma Recent Developments
  25. 6.5 FluGen
  26. 6.5.1 FluGen Company Information
  27. 6.5.2 FluGen Business Overview
  28. 6.5.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 FluGen Microneedle Flu Vaccine Product Portfolio
  30. 6.5.5 FluGen Recent Developments
  31. 6.6 Debiotech
  32. 6.6.1 Debiotech Company Information
  33. 6.6.2 Debiotech Business Overview
  34. 6.6.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Debiotech Microneedle Flu Vaccine Product Portfolio
  36. 6.6.5 Debiotech Recent Developments
  37. 6.7 CosMED Pharmaceuticals
  38. 6.7.1 CosMED Pharmaceuticals Company Information
  39. 6.7.2 CosMED Pharmaceuticals Business Overview
  40. 6.7.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
  42. 6.7.5 CosMED Pharmaceuticals Recent Developments
  43. 6.8 Corium International
  44. 6.8.1 Corium International Company Information
  45. 6.8.2 Corium International Business Overview
  46. 6.8.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Corium International Microneedle Flu Vaccine Product Portfolio
  48. 6.8.5 Corium International Recent Developments
  49. 6.9 Becton Dickinson and Company
  50. 6.9.1 Becton Dickinson and Company Company Information
  51. 6.9.2 Becton Dickinson and Company Business Overview
  52. 6.9.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
  54. 6.9.5 Becton Dickinson and Company Recent Developments
7 North America by Country
  1. 7.1 North America Microneedle Flu Vaccine Sales by Country
  2. 7.1.1 North America Microneedle Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Microneedle Flu Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Microneedle Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Microneedle Flu Vaccine Market Size by Country
  6. 7.2.1 North America Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Microneedle Flu Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Microneedle Flu Vaccine Sales by Country
  2. 8.1.1 Europe Microneedle Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Microneedle Flu Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Microneedle Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Microneedle Flu Vaccine Market Size by Country
  6. 8.2.1 Europe Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Microneedle Flu Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Microneedle Flu Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Microneedle Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Microneedle Flu Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Microneedle Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Microneedle Flu Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Microneedle Flu Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Microneedle Flu Vaccine Sales by Country
  2. 10.1.1 South America Microneedle Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Microneedle Flu Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Microneedle Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Microneedle Flu Vaccine Market Size by Country
  6. 10.2.1 South America Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Microneedle Flu Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Microneedle Flu Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Microneedle Flu Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Microneedle Flu Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Microneedle Flu Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Microneedle Flu Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Microneedle Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Microneedle Flu Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Microneedle Flu Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Microneedle Flu Vaccine Value Chain Analysis
  2. 12.1.1 Microneedle Flu Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Microneedle Flu Vaccine Production Mode & Process
  7. 12.2 Microneedle Flu Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Microneedle Flu Vaccine Distributors
  10. 12.2.3 Microneedle Flu Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst